Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performance

Author:

Rahalkar Hasumati12ORCID,Sheppard Alan3ORCID,Salek Sam24ORCID

Affiliation:

1. Regulatory Affairs, Metina PharmConsulting Pvt Ltd, Navi Mumbai, India

2. School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK

3. Business Development, Ascher Resources Ltd, London, UK

4. School of Pharmacy and Pharmaceutical Sciences, Institute of Medicines Development, Cardiff, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Reference101 articles.

1. Coherent Market Insights. Global biologics market to surpass US$ 456.83 8 Billion by 2027. Says CMI. 2020 Apr 03 [cited 2021 Mar 13]. Available from: https://www.globenewswire.com/news-release/2020/04/03/2011472/0/en/Global-Biologics-Market-to-surpass-US-456-83-8-Billion-by-2027-Says-CMI.html

2. IQVIA Institute. The global use of medicine in 2019 and outlook to 2023: forecasts and areas to watch. 2019 Jan 29 [cited 2021 Mar 13]. Available from; https://www.iqvia.com/insights/the-iqvia-institute/reports/the-global-use-of-medicine-in-2019-and-outlook-to-2023

3. Brice J, and Toscano D. GLOBAL BIOSIMILARS MARKET – Large opportunity due to patent expiries of blockbuster biologics. 2012 Nov-Dec [cited 2021 Apr 29]. Available from: https://drug-dev.com/global-biosimilars-market-large-opportunity-due-to-patent-expiries-of-blockbuster-biologics/

4. PR Newswire. Biosimilar Market- The Future For The Generic Pharmaceuticals Industry; 2020 Mar 13 [cited 2021 Apr 29]. Available from: https://www.biosimilardevelopment.com/doc/biosimilar-market-the-future-for-the-generic-pharmaceuticals-industry-0001#:~:text=The%20reported%20study%20estimated%20the,period%20(2019%2D2025).&text=A%20biosimilar%20is%20a%20biologic,known%20as%20a%20reference%20product

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Dynamics of biosimilar uptake in emerging markets;Expert Opinion on Biological Therapy;2022-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3